Dumont & Blake Investment Advisors LLC Has $276,000 Position in Clorox Company (The) (NYSE:CLX)

Dumont & Blake Investment Advisors LLC raised its position in shares of Clorox Company (The) (NYSE:CLX) by 0.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,074 shares of the company’s stock after buying an additional 1 shares during the period. Dumont & Blake Investment Advisors LLC’s holdings in Clorox Company (The) were worth $276,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CLX. American Beacon Advisors Inc. acquired a new stake in Clorox Company (The) during the first quarter worth $104,000. Parkside Financial Bank & Trust increased its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares in the last quarter. Valley National Advisers Inc. increased its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Finally, Blue Chip Partners Inc. increased its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. Institutional investors own 70.29% of the company’s stock.

Shares of Clorox Company (CLX) opened at 134.31 on Friday. The company has a 50 day moving average of $133.58 and a 200-day moving average of $133.56. The firm has a market cap of $17.34 billion, a price-to-earnings ratio of 25.18 and a beta of 0.40. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the previous year, the firm earned $1.30 earnings per share. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. Analysts predict that Clorox Company will post $5.67 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Dumont & Blake Investment Advisors LLC Has $276,000 Position in Clorox Company (The) (NYSE:CLX)” was first reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.thestockobserver.com/2017/08/12/dumont-blake-investment-advisors-llc-has-276000-position-in-clorox-company-the-nyseclx.html.

Several research analysts have commented on CLX shares. Vetr downgraded shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a research report on Tuesday, April 18th. Jefferies Group LLC started coverage on shares of Clorox Company (The) in a research note on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price on the stock. BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. BidaskClub cut shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and set a $137.00 target price (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply